InnoCare (诺诚健华) IPO Trading: At the Mercy of Retail Flipping
InnoCare, a China-based biotech company founded by a famous scientist, raised USD 270 million at HKD 8.95 per share. In this insight, we will cover...
427 Views
Peijia Medical (沛嘉医疗) Pre-IPO: Reminiscence of Venus Medtech?
Peijia Medical is a leading domestic player in the transcatheter valve therapeutic medical device market and the neurointerventional procedural...
1.2k Views
2019 Hong Kong IPO Analytics: How Did Insti and Retail Coverage Impact Deal Performance
Since the inception of our IPO research in 2015, the Aequitas Research team has covered over 452 IPOs, which raised over US$100m each, across the...
531 Views
Jiumaojiu (九毛九) Trading - Off to a Great Start with 638x Oversubscription
Jiumaojiu (9922 HK) raised about US$283m at HK$6.60 per share, the top end of its IPO price range. We have previously covered the IPO...
505 Views
Venus Medtech (启明医疗) IPO Trading: Allocation and Buy-Level
Venus Medtech, the dominant player in the heart valve replacement segment in China, raised USD 311 million at HKD 33.0 per share. In this insight,...
522 Views